Advanced Nanomaterials-Based Electrochemical Biosensors for Catecholamines Detection: Challenges and Trends

Area of Science:

• Neuroscience and Analytical Chemistry
• Focus on neurotransmitter analysis and biosensor technology.

Background:

• Catecholamines (dopamine, epinephrine, norepinephrine) are vital neurotransmitters in the CNS.
• Dysregulation is linked to neurological disorders like Parkinson's, Alzheimer's, and Epilepsy.
• Accurate analysis of catecholamines is crucial for early disease diagnosis and pharmaceutical research.

Purpose of the Study:

• To provide a comprehensive overview of recent advancements in catecholamine biosensors.
• To emphasize the role and mechanisms of electrochemical biosensors.
• To discuss the impact of nanotechnology on catecholamine detection.

Main Methods:

• Review of current literature on optical and electrochemical biosensors for catecholamines.
• Analysis of sensing mechanisms, particularly for electrochemical approaches.
• Evaluation of nanotechnology integration in biosensor design.

Main Results:

• Electrochemical biosensors show significant promise for real-time catecholamine monitoring.
• Nanotechnology offers unique characteristics enhancing biosensor performance.
• Biosensor performance metrics guide therapeutic and diagnostic applications.

Conclusions:

• Catecholamine biosensors are accelerating the early diagnosis of neurological diseases.
• Electrochemical biosensors, enhanced by nanotechnology, are key future tools.
• Further development is needed for optimized therapeutic and analytical applications.